Dow Down 1.07% Nasdaq Down 0.93%

Alcobra Ltd. (ADHD)

-NasdaqGM
2.51 Down 2.11(45.67%) Sep 29, 4:00PM EDT
Prev Close:4.62
Open:2.19
Bid:1.50 x 2000
Ask:N/A
1y Target Est:11.50
Beta:0.947672
Earnings Date:Nov 17 - Nov 24 (Est.)
Day's Range:1.95 - 2.58
52wk Range:1.95 - 8.78
Volume:9,779,198
Avg Vol (3m):244,255
Market Cap:69.18M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADHD

Comparison

Symbol% ChgMkt Cap
ADHDDown 45.67%69.18M
JNJDown 1.78%320.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.94
Quarterly EPS Est (Sep-16) :-0.26
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company is primarily developing MDX (metadoxine), an onset/extended release formulation of the chemical pyridoxine pyroglutama... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback